DACC programs

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDACC programs
Drug Alias NameN/A
ClassificationSmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSilence Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A